Device Trial Radar · NCT04035356
HAART Annuloplasty Device Valve Repair Registry
Last checked: Nov 20, 2026Latest source record: Aug 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
183
Actual
Start
Sep 22, 2020
Primary completion
Jul 25, 2024
Study completion Jul 25, 2024
Sponsor
- Lead sponsor
- Biostable Science & EngineeringNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 29, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multicenter US registry study to assess procedure success and long-term (10-year) performance of the HAART 200 and HAART 300 Aortic Annuloplasty Devices when used during aortic valve repair in a routine cardiovascular practice setting.
Conditions
- Aortic Valve Insufficiency
- Aortic Aneurysm
Interventions
Aortic valve repairDevice
Use of a HAART Aortic Annuloplasty Device in patients undergoing aortic valve repair surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from aortic valve reoperationTime frame: 10 years
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Franciscan Health Indianapolis
Indianapolis, Indiana
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.